As we have previously reported, total (cytoplasmic and nuclear) NR4A1 expression is significantly reduced in aggressive lymphoma specimens when compared to non-neoplastic germinal centre B cells (GC-B)9. This evidence concerns the gene NR4A1 and lymphoma.